Pivotal Study of the Velocity™ pAVF System

NARecruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

October 21, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2030

Conditions
Chronic Kidney DiseaseHemodialysis AccessArteriovenous FistulaEnd Stage Renal Disease (ESRD)
Interventions
DEVICE

Velocity Percutaneous Arteriovenous Fistula

The Velocity pAVF is a catheter-based device used to create an arteriovenous fistula for hemodialysis access through a minimally invasive, percutaneous procedure. Unlike surgical AVF creation or other pAVF systems, Velocity is designed to simplify the procedure and improve consistency of maturation and long-term function. All participants in this study will undergo AVF creation using the Velocity pAVF.

Trial Locations (2)

36301

RECRUITING

Trinity Research Group, Dothan

92505

NOT_YET_RECRUITING

Apex Research, Riverside

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Venova Medical

INDUSTRY

NCT07153939 - Pivotal Study of the Velocity™ pAVF System | Biotech Hunter | Biotech Hunter